Jacques Henri Max Cohen

Prof. Jacques Henri Max Cohen


Research Focus & Metrics

Academic Career Length

46Years (1981-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2004 in Analytical Biochemistry
Verified
Journal Article
Closed access
ASAlyona Sukhanova
Alyona Sukhanova
Jerome DevyJerome Devy
Jerome Devy
LVLydie Venteo
Lydie Venteo
HKHervé Kaplan
Hervé Kaplan
MAMikhail Artemyev
Mikhail Artemyev
Igor NabievIgor Nabiev
Igor Nabiev

1 December 1983 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
JCJacques Henri Max Cohen
Jacques Henri Max Cohen
LDL Danel
L Danel
GCG Cordier
G Cordier
SSS Saez
S Saez
JRJ P Revillard
J P Revillard
The immune response has been reported to be modulated by sex hormones in several models, and estrogen receptors have been demonstrated in the human thymus. We therefore investigated the presence of estrogen and androgen receptors among human peripheral T cells; thoracic duct lymph provided large amounts of circulating lymphocytes. Pure T cells were obtained by negative selection by using complement-dependent cytotoxicity with a monoclonal antibody against a monomorphic determinant of class II histocompatibility antigen (HLA-DR). Furthermore, subsets of OKT8-positive and OKT8-negative lymphocytes were selected by using an OKT8-like monoclonal antibody. Sex steroid binding was determined on purified nuclei; no androgen receptors could be demonstrated on peripheral T cells. The cytoplasmic [3H] 17-beta-estradiol-receptor complex was always translocated to the nucleus in vitro within 1 hr at 37 degrees C; no estrogen receptors were demonstrable on purified OKT4-positive subsets. Assuming that estrogen receptors were evenly distributed among OKT8-positive cells, their level could be estimated to be about 40 fmol/mg DNA. The restriction of estrogen receptors to T cells bearing the "suppressor-cytotoxic" phenotype suggests a possible pathway for the modulation of T cell suppressive activities by estrogens.

1 October 1985 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
MRM Reynes
M Reynes
JAJ P Aubert
J P Aubert
JCJacques Henri Max Cohen
Jacques Henri Max Cohen
JAJ Audouin
J Audouin
VTV Tricottet
V Tricottet
MKM D Kazatchkine
M D Kazatchkine
The expression of complement receptors by human follicular dendritic cells (FDC) was investigated by immunohistochemical techniques by using polyclonal and monoclonal antibodies to antigenic determinants of CR1, CR2, and CR3. Upon optical immunohistochemical examination of frozen sections from human reactive lymph nodes and tonsils by a three-step immunoperoxidase technique, a strong staining of cell bodies and cytoplasmic extensions of FDC was observed in germinal centers with anti-CR1 and anti-CR2 antibodies. Staining for these antigens was also found on cytoplasmic extensions of FDC in the mantle zone and on the plasma membrane of B cells in the entire follicles. Staining of FDC with anti-CR2 antibody was more intense than that of B lymphocytes. Monoclonal antibodies directed against epitopes of the alpha-chain of CR3 weakly stained FDC in follicles in a similar pattern to that which was observed on adjacent sections with mouse monoclonal antibody KIM4 that only recognizes FDC in human lymph nodes. Immunoelectron-microscopy was performed on frozen sections of a lymph node involved with a centroblastic centrocytic B malignant lymphoma and a reactive tonsil with the use of rabbit F(ab')2 anti-CR1 antibodies and mouse monoclonal anti-CR2 antibody. All the plasma membrane of the cell body and cytoplasmic extensions of FDC in germinal centers and in the mantle zones homogeneously stained for CR1 and CR2 antigens. Fibroblastic reticulum cells were negative. The plasma membrane of tumoral B lymphocytes strongly stained with anti-CR1 and weakly stained with anti-CR2 antibodies. The presence of CR1, CR2, and CR3 on FDC is a unique surface characteristic of these cells that should optimally allow the cells to bind antigen/antibody complexes bearing any type of C3 fragment.

1 May 2012 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
ASAlyona Sukhanova
Alyona Sukhanova
KEKlervi Even-Desrumeaux
Klervi Even-Desrumeaux
AKAymric Kisserli
Aymric Kisserli
TTThierry Tabary
Thierry Tabary
BRBrigitte Reveil
Brigitte Reveil
Igor NabievIgor Nabiev
Igor Nabiev

1 November 1994 in Virology
Verified
Journal Article
Closed access
PCPierre Charneau
Pierre Charneau
ABAndy Borman
Andy Borman
CQCaroline Quillent
Caroline Quillent
DGDenise Guétard
Denise Guétard
SCSophie Chamaret
Sophie Chamaret
FCFrançois Clavel
François Clavel

11 January 2006 in Langmuir
Verified
Journal Article
Closed access
NJNancy Joumaa
Nancy Joumaa
MLMuriel Lansalot
Muriel Lansalot
ATAlain Théretz
Alain Théretz
Abdelhamid ElaissariAbdelhamid Elaissari
Abdelhamid Elaissari
ASAlyona Sukhanova
Alyona Sukhanova
JCJacques Henri Max Cohen
Jacques Henri Max Cohen